255 related articles for article (PubMed ID: 17917832)
1. Capecitabine and oxaliplatin (XELOX) is safe and effective in patients with advanced gastric cancer.
Quek R; Lim WT; Foo KF; Koo WH; A-Manaf A; Toh HC
Acta Oncol; 2007; 46(7):1032-4. PubMed ID: 17917832
[No Abstract] [Full Text] [Related]
2. [Preliminary study of XELOX regimen as the first-line chemotherapy in advanced or recurrent gastric cancer].
Min N; He BF; Zhang LS; Liao H; Jia YZ
Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar; 30(3):599-601. PubMed ID: 20335149
[TBL] [Abstract][Full Text] [Related]
3. [Oxaliplatin combined with capecitabine as first-line chemotherapy for patients with advanced gastric cancer].
Dong NN; Wang MY; Zhang Q; Liu ZF
Ai Zheng; 2009 Apr; 28(4):412-5. PubMed ID: 19622303
[TBL] [Abstract][Full Text] [Related]
4. Modified FOLFOX-4 as first-line and salvage treatment in advanced gastric cancer.
Baek YH; Choi SR; Jang JS; Roh MH; Lee JH; Won JJ; Lee CM
Hepatogastroenterology; 2011; 58(105):251-6. PubMed ID: 21510324
[TBL] [Abstract][Full Text] [Related]
5. Interstitial lung diseases in patients treated with oxaliplatin, 5-fluorouracil and leucovorin (FOLFOX).
Jung KH; Kil SY; Choi IK; Seo JH; Shin C; Kim YS; Kim JH
Int J Tuberc Lung Dis; 2006 Oct; 10(10):1181-2. PubMed ID: 17044215
[No Abstract] [Full Text] [Related]
6. Comparison between DCF (Docetaxel, Cisplatin and 5-Fluorouracil) and modified EOX (Epirubicin, Oxaliplatin and Capecitabine) as palliative first-line chemotherapy for adenocarcinoma of the upper gastrointestinal tract.
Ilhan-Mutlu A; Preusser M; Schoppmann SF; Asari R; Ba-Ssalamah A; Schwameis K; Pluschnig U; Birner P; Püspök A; Zacherl J; Hejna M
Anticancer Res; 2013 Aug; 33(8):3455-9. PubMed ID: 23898119
[TBL] [Abstract][Full Text] [Related]
7. Capecitabine plus oxaliplatin (XELOX) compared with 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOXs) in advanced gastric cancer: meta-analysis of randomized controlled trials.
Xu HB; Huang F; Su R; Shen FM; Lv QZ
Eur J Clin Pharmacol; 2015 May; 71(5):589-601. PubMed ID: 25795200
[TBL] [Abstract][Full Text] [Related]
8. Oxaliplatin combined with continuous infusion of 5-fluorouracil as first-line chemotherapy in patients with metastatic or recurrent gastric adenocarcinoma.
Lim JY; Cho JY; Oh KJ; Choi SH; Lee SI; Jeung HC
Chemotherapy; 2009; 55(4):200-6. PubMed ID: 19451710
[TBL] [Abstract][Full Text] [Related]
9. Xelox (capecitabine plus oxaliplatin) as neoadjuvant chemotherapy of unresectable liver metastases in colorectal cancer patients.
Coskun U; Buyukberber S; Yaman E; Uner A; Er O; Ozkan M; Dikilitas M; Oguz M; Yildiz R; B DY; Kaya AO; Benekli M
Neoplasma; 2008; 55(1):65-70. PubMed ID: 18190244
[TBL] [Abstract][Full Text] [Related]
10. Nerve, muscle and heart acute toxicity following oxaliplatin and capecitabine treatment.
Orsucci D; Pizzanelli C; Alì G; Calabrese R; Ricci G; Lenzi P; Petrozzi L; Moretti P; Siciliano G
Neuromuscul Disord; 2012 Aug; 22(8):767-70. PubMed ID: 22652078
[TBL] [Abstract][Full Text] [Related]
11. Are capecitabine and oxaliplatin (XELOX) suitable treatments for progressing low-grade and high-grade neuroendocrine tumours?
Bajetta E; Catena L; Procopio G; De Dosso S; Bichisao E; Ferrari L; Martinetti A; Platania M; Verzoni E; Formisano B; Bajetta R
Cancer Chemother Pharmacol; 2007 Apr; 59(5):637-42. PubMed ID: 16937105
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of oxaliplatin, fluorouracil and folinic acid (FOLFOX-6) as first-line chemotherapy in advanced or recurrent gastric cancer.
Luo HY; Xu RH; Zhang L; Li YH; Shi YX; Lin TY; Han B; Wang F; Qiu MZ; He YJ; Guan ZZ
Chemotherapy; 2008; 54(3):228-35. PubMed ID: 18560231
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of preoperative chemotherapy regimens in patients with initially unresectable locally advanced gastric adenocarcinoma: capecitabine and oxaliplatin (XELOX) or with epirubicin (EOX).
Wang Y; Zhuang RY; Yu YY; Yu S; Hou J; Ji Y; Sun YH; Shen KT; Shen ZB; Liu FL; Zhao NQ; Liu TS
Oncotarget; 2016 Nov; 7(46):76298-76307. PubMed ID: 27602586
[TBL] [Abstract][Full Text] [Related]
14. Patterns of hepatotoxicity after chemotherapy for colorectal cancer liver metastases.
Kandutsch S; Klinger M; Hacker S; Wrba F; Gruenberger B; Gruenberger T
Eur J Surg Oncol; 2008 Nov; 34(11):1231-6. PubMed ID: 18272318
[TBL] [Abstract][Full Text] [Related]
15. Hand-foot syndrome related to chemotherapy.
Qiao J; Fang H
CMAJ; 2012 Oct; 184(15):E818. PubMed ID: 22508979
[No Abstract] [Full Text] [Related]
16. [Treatment of advanced gastric cancer with oxaliplatin plus 5-fluorouracil/ leucovorin (FOLFOX-4 chemotherapy)].
Garrido M; Melgoza G; Galindo H; Madrid J; Sánchez C; Nervi B; Alvarez M; Orellana E
Rev Med Chil; 2007 Nov; 135(11):1380-7. PubMed ID: 18259648
[TBL] [Abstract][Full Text] [Related]
17. New recommendation of doses in an ongoing phase II study of docetaxel, oxaliplatin and capecitabine as first line therapy in advanced gastro-oesophageal cancer.
Schønnemann KR; Yilmaz M; Andersen M; Pfeiffer P
Acta Oncol; 2011 Jan; 50(1):151-2. PubMed ID: 20843172
[No Abstract] [Full Text] [Related]
18. Phase 2 trial of oxaliplatin plus capecitabine (XELOX) as second-line therapy for patients with advanced pancreatic cancer.
Xiong HQ; Varadhachary GR; Blais JC; Hess KR; Abbruzzese JL; Wolff RA
Cancer; 2008 Oct; 113(8):2046-52. PubMed ID: 18756532
[TBL] [Abstract][Full Text] [Related]
19. Treatment outcomes of oxaliplatin, 5-FU, and leucovorin as salvage therapy for patients with advanced or metastatic gastric cancer: a retrospective analysis.
Seo HY; Kim DS; Choi YS; Sung HJ; Park KH; Choi IK; Kim SJ; Oh SC; Seo JH; Choi CW; Kim BS; Shin SW; Kim YH; Kim JS
Cancer Chemother Pharmacol; 2009 Feb; 63(3):433-9. PubMed ID: 18398608
[TBL] [Abstract][Full Text] [Related]
20. Capecitabine: new indication. Advanced-stage gastric cancer: oral route for some patients. Risk of palmoplantar erythrodysaesthesia.
Prescrire Int; 2008 Jun; 17(95):107. PubMed ID: 18627118
[No Abstract] [Full Text] [Related]
[Next] [New Search]
